Spine Surg Relat Res, 2022 · DOI: 10.22603/ssrr.2022-0004 · Published: October 1, 2022
This study investigates the use of mesenchymal stem cell-derived conditioned media (MSC-CM) as a potential treatment for spinal cord injury (SCI) in animal models. Conditioned media may be a desirable alternative to cell therapy. The research focuses on whether MSC-CM can improve movement after SCI, offering a possible solution without the limitations of directly transplanting stem cells. MSC-CM may be a desirable alternative for MSCs in the treatment of SCI, since it does not have the limitations of MSCs. A meta-analysis was performed to consolidate the findings of multiple studies, aiming to provide a clearer understanding of MSC-CM's effectiveness in promoting motor recovery after SCI. Thus, the present systematic review and meta-analysis aims to investigate the efficacy of MSC-CM transplantation in the treatment motor deteriorations in ani-
MSC-CM administration may offer a new therapeutic avenue for promoting motor recovery after SCI.
The study suggests that higher doses of MSC-CM (greater than 120 μL) may be more effective in improving motor function.
MSC-CM treatment can be considered as an alternative treatment approach in translational studies.